Your browser doesn't support javascript.
loading
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial.
Lu, Juming; Fu, Liujun; Li, Yan; Geng, Jianlin; Qin, Li; Li, Ping; Zheng, Hailong; Sun, Zilin; Li, Yanbing; Zhang, Lihui; Sun, Yadong; Chen, Daoxiong; Qin, Guijun; Lu, Weiping; Guo, Yushan; Zhang, Yuwei; Liu, Haiyan; Zhang, Tao; Zou, Jianjun.
Afiliação
  • Lu J; Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.
  • Fu L; Department of Endocrinology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
  • Li Y; Department of Endocrinology, Chongqing Sanxia Central Hospital, Chongqing, China.
  • Geng J; Department of Endocrinology, Harrison International Peace Hospital, Hengshui, China.
  • Qin L; Department of Endocrinology, Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li P; Department of Endocrinology, Yuncheng Central Hospital, Yuncheng, China.
  • Zheng H; Department of Endocrinology, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
  • Sun Z; Department of Endocrinology, Zhongda Hospital Affiliated to Southeast University, Nanjing, China.
  • Li Y; Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang L; Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Sun Y; Department of Endocrinology, Jilin Province People's Hospital, Changchun, China.
  • Chen D; Department of Endocrinology, Hainan General Hospital, Haikou, China.
  • Qin G; Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Lu W; Department of Endocrinology, The First Affiliated Huai'an Hospital of Nanjing Medical University, Huai'an, China.
  • Guo Y; Department of Endocrinology, The Affiliated Hospital of Beihua University, Jilin, China.
  • Zhang Y; Department of Endocrinology, West China Hospital of Sichuan University, Chengdu, China.
  • Liu H; Jiangsu Hengrui Medicine Co. Ltd, Shanghai, China.
  • Zhang T; Jiangsu Hengrui Medicine Co. Ltd, Shanghai, China.
  • Zou J; Jiangsu Hengrui Medicine Co. Ltd, Shanghai, China.
Diabetes Obes Metab ; 23(5): 1111-1120, 2021 05.
Article em En | MEDLINE | ID: mdl-33417292
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China